Maternal, Child and Adolescent Health Program, Burnet Institute, Melbourne, Australia.
Gender and Women's Health Unit, Centre for Health Equity, School of Population and Global Health, University of Melbourne, Melbourne, Australia.
PLoS One. 2022 Sep 1;17(9):e0272982. doi: 10.1371/journal.pone.0272982. eCollection 2022.
Over 10% of maternal deaths annually are due to sepsis. Prophylactic antibiotics and antiseptic agents are critical interventions to prevent maternal peripartum infections. We conducted a mixed-method systematic review to better understand factors affecting the use of prophylactic antibiotics and antiseptic agents to prevent peripartum infections.
We searched MEDLINE, EMBASE, Emcare, CINAHL, Global Health, Global Index Medicus, and Maternity and Infant Care for studies published between 1 January 1990 and 27 May 2022. We included primary qualitative, quantitative, and mixed-methods studies that focused on women, families, and healthcare providers' perceptions and experiences of prophylactic antibiotic and antiseptics during labour and birth in health facilities. There were no language restrictions. We used a thematic synthesis approach for qualitative evidence and GRADE-CERQual approach for assessing confidence in these review findings. Quantitative study results were mapped to the qualitative findings and reported narratively.
We included 19 studies (5 qualitative, 12 quantitative and 2 mixed-methods studies), 16 relating to antibiotics, 2 to antiseptic use, and 1 study to both antibiotic and antiseptic use. Most related to providers' perspectives and were conducted in high-income countries. Key themes on factors affecting antibiotic use were providers' beliefs about benefits and harms, perceptions of women's risk of infection, regimen preferences and clinical decision-making processes. Studies on antiseptic use explored women's perceptions of vaginal cleansing, and provider's beliefs about benefits and the usefulness of guidelines.
We identified a range of factors affecting how providers use prophylactic antibiotics at birth, which can undermine implementation of clinical guidelines. There were insufficient data for low-resource settings, women's perspectives, and regarding use of antiseptics, highlighting the need for further research in these areas. Implications for practice include that interventions to improve prophylactic antibiotic use should take account of local environments and perceived infection risk and ensure contextually relevant guidance.
每年有超过 10%的孕产妇死亡是由于败血症。预防性抗生素和消毒剂是预防孕产妇围产期感染的关键干预措施。我们进行了一项混合方法系统评价,以更好地了解影响预防性抗生素和消毒剂使用以预防围产期感染的因素。
我们检索了 MEDLINE、EMBASE、Emcare、CINAHL、全球健康、全球索引医学和母婴保健,以获取 1990 年 1 月 1 日至 2022 年 5 月 27 日期间发表的研究。我们纳入了主要关注女性、家庭和医疗保健提供者对产时预防性抗生素和消毒剂的看法和经验的定性、定量和混合方法研究,这些研究在卫生设施中进行。没有语言限制。我们使用主题综合方法对定性证据进行评估,并使用 GRADE-CERQual 方法评估这些综述结果的可信度。定量研究结果与定性研究结果进行映射,并以叙述方式报告。
我们纳入了 19 项研究(5 项定性研究、12 项定量研究和 2 项混合方法研究),其中 16 项与抗生素使用有关,2 项与消毒剂使用有关,1 项与抗生素和消毒剂使用有关。大多数研究与提供者的观点有关,并且是在高收入国家进行的。影响抗生素使用的主要因素包括提供者对益处和危害的看法、对女性感染风险的看法、方案偏好和临床决策过程。关于消毒剂使用的研究探讨了女性对阴道清洗的看法,以及提供者对益处和指南有用性的看法。
我们确定了影响提供者在分娩时使用预防性抗生素的一系列因素,这些因素可能会破坏临床指南的实施。在资源匮乏的环境中、女性观点以及消毒剂使用方面的数据不足,这突出表明需要在这些领域进一步研究。对实践的影响包括,为改善预防性抗生素使用而采取的干预措施应考虑到当地环境和感知的感染风险,并确保提供与背景相关的指导。